Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Issuance of Controlled Copies of SOPs – V 2.0

Posted on By

API Manufacturing: SOP for Issuance of Controlled Copies of SOPs – V 2.0

Standard Operating Procedure for Issuance of Controlled Copies of SOPs in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/196/2025
Supersedes SOP/API/196/2022
Page No. Page 1 of 15
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the procedure for issuing, controlling, and retrieving controlled copies of Standard Operating Procedures (SOPs) to ensure only the latest approved versions are in use across departments involved in API manufacturing, and obsolete versions are securely withdrawn.

2. Scope

This SOP applies to all printed and

electronic controlled copies of SOPs distributed by the Quality Assurance (QA) department to user departments within the API manufacturing unit. It includes issuance, stamping, acknowledgment, revision control, and retrieval processes.

3. Responsibilities

  • QA Documentation Officer: Maintains master and controlled copies, logs issuance, retrieves obsolete copies, and ensures document control compliance.
  • Department Heads: Ensure that only current versions of SOPs are available at points of use and obsolete versions are promptly returned.
  • QA Manager: Approves issuance and ensures periodic review of document control system.
See also  API Manufacturing: SOP for Destruction of Used IPC Samples - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring only approved, current, and authorized SOP versions are in circulation and use throughout the facility.

5. Procedure

5.1 Classification of Copies

  1. Master Copy: The original signed version stored under QA control (Annexure-1).
  2. Controlled Copy: A QA-authorized and stamped copy issued for use in respective departments (Annexure-2).
  3. Uncontrolled Copy: Any copy printed or shared for training or reference without issuance tracking and QA stamp; these must be marked “Uncontrolled.”

5.2 Issuance of Controlled Copies

  1. QA shall print copies of the SOP upon approval using the final signed and dated Master Copy.
  2. Each copy shall be:
    • Stamped as “CONTROLLED COPY” in red ink
    • Sequentially numbered as CC-01, CC-02, etc.
    • Signed and dated by the QA Documentation Officer
  3. Details of each issued copy shall be logged in the Controlled Copy Issuance Register (Annexure-3).

5.3 Distribution and Acknowledgment

  1. Controlled copies are distributed to departments against acknowledgment in the SOP Acknowledgment Form (Annexure-4).
  2. The receiving department must:
    • Verify the copy and confirm receipt
    • Ensure filing in designated SOP file holder
    • Replace previous versions immediately
See also  API Manufacturing: SOP for Fire Hazard Control Measures - V 2.0

5.4 Retrieval of Obsolete SOPs

  1. Upon revision of an SOP:
    • QA issues the new controlled version
    • The old version is withdrawn and marked “OBSOLETE” in red
  2. Obsolete copies are recorded in the Obsolete SOP Control Log (Annexure-5) and stored in a dedicated QA archive file marked “RETIRED SOPs.”

5.5 Access and Storage

  1. Controlled copies must be stored in a central, easily accessible location within the department’s documentation area.
  2. Electronic SOPs accessed via DMS must follow the same control rules with system-based user access rights.

5.6 Audit and Reconciliation

  1. QA shall conduct quarterly SOP audits across departments using the SOP Reconciliation Checklist (Annexure-6) to ensure:
    • Only current versions are in use
    • No handwritten changes exist
    • Copies are legible, intact, and filed properly

6. Abbreviations

  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
  • CC: Controlled Copy
  • DMS: Document Management System

7. Documents

  1. Master SOP Register (Annexure-1)
  2. Controlled Copy Distribution Record (Annexure-2)
  3. Controlled Copy Issuance Register (Annexure-3)
  4. SOP Acknowledgment Form (Annexure-4)
  5. Obsolete SOP Control Log (Annexure-5)
  6. SOP Reconciliation Checklist (Annexure-6)

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO TRS 986 Annex 2 – Good Documentation Practices
  • 21 CFR Part 211.100 – Written Procedures
  • EU GMP Chapter 4 – Documentation
See also  API Manufacturing: SOP for Handling of Returned Drug Product - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Master SOP Register

SOP No. Title Version Effective Date Status
SOP/API/025/2025 Granulation Procedure V2.0 01/03/2025 Active

Annexure-2: Controlled Copy Distribution Record

SOP No. CC No. Issued To Department Date
SOP/API/025/2025 CC-03 Rajesh Kumar Production 02/03/2025

Annexure-3: Controlled Copy Issuance Register

SOP No. Copy No. Issued To Issued By Date
SOP/API/010/2025 CC-01 QC Lab QA Officer 05/04/2025

Annexure-4: SOP Acknowledgment Form

SOP No. Version Receiver Name Signature Date
SOP/API/010/2025 2.0 Sunita Reddy 05/04/2025

Annexure-5: Obsolete SOP Control Log

SOP No. Version Obsoleted On Withdrawn From Archived By
SOP/API/010/2022 V1.0 05/04/2025 QA Office QA Officer

Annexure-6: SOP Reconciliation Checklist

Department SOP Title Version Compliant Remarks
Production Weighing of API V2.0 Yes Filed correctly

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Version New SOP Creation QA Head
14/04/2025 2.0 Added reconciliation and acknowledgment process Internal Audit Recommendation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for pH Testing of Injectable Products – V 2.0
Next Post: Biosimilars: SOP for Emergency Shutdown of Bioreactor – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version